About this trial

This study investigates the feasibility and impact of patient access to clinical notes written by their healthcare providers-a concept known as Open Notes. While international research has already demonstrated positive effects of Open Notes on patient empowerment and treatment outcomes, there is a lack of corresponding evidence for the German healthcare context. The quasi-experimental study therefore combines quantitative and qualitative methods to evaluate the effects of Open Notes on patient-reported outcomes as well as clinical practice.

The study is structured into five modules, each addressing specific research questions:

Module A - Summative Outcome Evaluation in Patients: Does the use of Open Notes lead to a significant increase in patient-reported outcomes such as empowerment and self-efficacy? Module B - Formative Process Evaluation with Stakeholders: What experiences do patients, relatives and clinicians have with Open Notes and what challenges and barriers arise in their use? Module C - Changes in Clinical Documentation: How do language style and content of clinical notes change when they are shared with patients as Open Notes? Module D - Optimization through Artificial Intelligence: Can clinical notes be processed using artificial intelligence in a way that makes them easier for patients to understand compared to conventional medical documentation? Module E - Integration into National Data Infrastructure: What technical, organizational and legal requirements must be met to successfully integrate Open Notes into the national telematics infrastructure and the electronic health record or routine care? The overall goal is to identify both patient-related outcomes and structural conditions for the sustainable implementation of Open Notes in the German healthcare system. The use of artificial intelligence is intended to further enhance patient-centeredness while reducing the burden on clinical staff.

Eligibility criteria

Qualifiers

Aged 18 years or older

Outpatient treatment at one of the four study centers

For intervention group: access to an internet-enabled device (e.g. smartphone, tablet, computer) and ability to receive text messages

Experience with the respective disease or medical field (e.g. via prior treatment experience or basic medical understanding)

Disqualifiers

Insufficient German language skills

Severe organic brain disorders with cognitive impairment

Intellectual disability

Acute self-endangerment or danger to others at time of inclusion

Trial design

Treatments tested in this trial

  • Patient Portal-Based Access to Clinical Notes

Treatment groups

1,092 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Julian Schwarz

Lead sponsor

Medizinische Hochschule Brandenburg Theodor Fontane

Sponsor institution

Universität zu Köln

Collaborator

Technische Hochschule Brandenburg

Collaborator